APA (7th ed.) Citation

P, T., M, V., & K, R. (2025). Pre-clinical Evaluation of Karanjin Against DMBA-Induced Breast Cancer in Female Sprague-Dawley Rats Through Modulation of SMAR1 and CDP/CUx genes. Naunyn-Schmiedeberg's archives of pharmacology, 398(2), 1825. https://doi.org/10.1007/s00210-024-03389-w

Chicago Style (17th ed.) Citation

P, Tirgar, Vekaria M, and Raval K. "Pre-clinical Evaluation of Karanjin Against DMBA-Induced Breast Cancer in Female Sprague-Dawley Rats Through Modulation of SMAR1 and CDP/CUx Genes." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 2 (2025): 1825. https://doi.org/10.1007/s00210-024-03389-w.

MLA (9th ed.) Citation

P, Tirgar, et al. "Pre-clinical Evaluation of Karanjin Against DMBA-Induced Breast Cancer in Female Sprague-Dawley Rats Through Modulation of SMAR1 and CDP/CUx Genes." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 2, 2025, p. 1825, https://doi.org/10.1007/s00210-024-03389-w.